BioPharma Pharma QC
Cherwell reaches custom cleanroom product development milestone in its 50th year
Cherwell Laboratories, specialists in cleanroom microbiology solutions, announces in its 50th anniversary year that it has successfully develope...
June 29, 2021 | News
SP launches SP Hull LyoStar(R) 4.0 to enhance speed to market in drug development
New advanced pilot-scale lyophilizer supports rapid and highly effective freezedry cycle development, optimization and process scale-up Based on a...
June 23, 2021 | News
Innovent Biologics Announces the Approval of Pemazyre® (pemigatinib) in Taiwan Market
Innovent Biologics, Inc. (Innovent) (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medi...
June 22, 2021 | News
MSD Announces Supply Agreement with U.S. Govt. for Molnupiravir
Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced it has entered into a procurement agreement with&...
June 21, 2021 | News
Novo Nordisk Plans Global Expansion With Amalgam Rx
Amalgam Rx, Inc., the leader in connecting healthcare providers and life sciences companies through a SaaS-enabled digital marketplace and product platform...
June 17, 2021 | News
Avantor® Completes Acquisition of Ritter GmbH and its Affiliates
By combining Ritter's liquid dispensing platform for clinical diagnostic testing and life sciences research with Avantor's offerings for critical lab autom...
June 12, 2021 | News
Innovative Mass Spectrometer Designed for Small Molecule Analysis
Small molecule researchers in academia, pharmaceutical, and biopharmaceutical industries can now use a new, intelligent mass spectrometer (MS) to reveal co...
June 08, 2021 | News
Samsung Pharm & GemVax present pancreatic cancer immunotherapeutic drug, RIAVAX™
ASCO 2021, which celebrates its 57th anniversary this year, runs from June 4th to June 8th and will be held virtually due to COVID-19. Some ...
June 07, 2021 | News
Liminal BioSciences Update Clinical Activities for Fezagepras
Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), a clinical-stage biopharmaceutical company, announced today that bas...
May 31, 2021 | News
PerkinElmer to acquire Nexcelom Bioscience for $260 Million in cash.
PerkinElmer, Inc. (NYSE: PKI) is pleased to announce it has entered into an agreement to acquire Nexcelom Bioscience for $260 Million&...
May 17, 2021 | News
Advancing gene therapy by solving challenges in scale-up & manufacturing
Dr. Brophy shares additional insight about how producing viral vectors can be made more efficient, the lessons that can be learned from manufacturing mAbs ...
May 11, 2021 | Influencers
Most Read
- 25 Biopharma Leaders Shaping a Sustainable 2025: Innovation Meets Environmental Responsibility
- 25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine
- Mr. Brendan O’Callaghan Discusses Sanofi’s Singapore Modulus Facility: Advancing Biopharma Manufacturing and Pandemic Preparedness
- Shaping the Future of PCV Care: Insights from Roche’s Stefan Scheidl on the SALWEEN Trial
- Pam Cheng Outlines AstraZeneca’s Bold Vision for Singapore’s First End-to-End ADC Manufacturing Facility
- Shaping a Health Innovation Hub: Alessandro Falcone Reflects on JLABS Singapore’s Milestone Year and Future Goals
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
